Developmental Epidemiology of Pediatric Anxiety Disorders

Funding

This work was supported by the Yung Family Foundation (JRS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) through R01HD099775 (JRS) and R01HD098757 (JRS), and by Cincinnati Children's Hospital Medical Center, United States under Strategic Partnership Projects agreement NFE-21-08617. This book article has been partially authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the US Department of Energy. This work was supported by the Yung Family Foundation (JRS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) through R01HD099775 (JRS) and R01HD098757 (JRS), and by Cincinnati Children's Hospital Medical Center, United States under Strategic Partnership Projects agreement NFE-21-08617. This book article has been partially authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the US Department of Energy. Dr J.R. Strawn has received research support from the Yung Family Foundation, the National Institutes of Health (NIMH/NIEHS/NICHD), the National Center for Advancing Translational Sciences, United States, the Patient-Centered Outcomes Research Institute, United States and Abbvie, United States. He has received material support from Myriad Health and royalties from three texts (Springer). Dr J.R. Strawn serves as an author for UpToDate and an Associate Editor for Current Psychiatry and has provided consultation to the FDA, Cereval, and IntraCellular Therapeutics. Views expressed within this article represent those of the authors and are not intended to represent the position of NIMH, United States, the National Institutes of Health, United States, or the Department of Health and Human Services. Dr J.R. Strawn has received research support from the Yung Family Foundation , the National Institutes of Health ( NIMH / NIEHS/NICHD ), the National Center for Advancing Translational Sciences, United States , the Patient-Centered Outcomes Research Institute, United States and Abbvie, United States . He has received material support from Myriad Health and royalties from three texts (Springer). Dr J.R. Strawn serves as an author for UpToDate and an Associate Editor for Current Psychiatry and has provided consultation to the FDA, Cereval, and IntraCellular Therapeutics. Views expressed within this article represent those of the authors and are not intended to represent the position of NIMH, United States, the National Institutes of Health, United States, or the Department of Health and Human Services.